Global Cord Blood Corp — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/cef0dae4-12db-4769-9c73-0bc580bcde52/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $79.0M | 2021-04-01 – 2022-03-31 | evidence 0001104659-22-091776 |
| FY 2020 | $77.6M | 2020-04-01 – 2021-03-31 | evidence 0001104659-21-097584 |
| FY 2019 | $66.5M | 2019-04-01 – 2020-03-31 | evidence 0001104659-20-087822 |
| FY 2018 | $43.4M | 2018-04-01 – 2019-03-31 | evidence 0001104659-19-041461 |
| FY 2017 | $37.8M | 2017-04-01 – 2018-03-31 | evidence 0001104659-18-046514 |
| FY 2016 | $18.3M | 2016-04-01 – 2017-03-31 | evidence 0001104659-17-046810 |
| FY 2015 | $14.1M | 2015-04-01 – 2016-03-31 | evidence 0001104659-16-135012 |
| FY 2014 | $17.3M | 2014-04-01 – 2015-03-31 | evidence 0001104659-15-055036 |
| FY 2013 | $21.2M | 2013-04-01 – 2014-03-31 | evidence 0001104659-14-055216 |
| FY 2012 | $18.1M | 2012-04-01 – 2013-03-31 | evidence 0001144204-13-042083 |
| FY 2011 | $21.0M | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-034224 |
| FY 2010 | — | 2010-04-01 – 2011-03-31 | evidence 0001144204-12-034224 |
| FY 2009 | — | 2009-04-01 – 2010-03-31 | evidence 0001144204-12-041827 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Global Cord Blood Corp — all facts · Revenue · Operating Income